NCT03936452
- Conditions
- Anlotinib, Early Stage, Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type, +5 more
- Locations
-
- Sun Yat-Sen University Cancer Center Guangzhou, Guangdong, China
Clinical trial condition
Phase Two
Explore clinical trials studying Phase Two. Study availability and eligibility vary by location and protocol.
1 public trial
0 recruiting studies